HDAC6 can control tumor growth and halt metastasis in triple-negative breast cancer

(George Washington University) Genetic modifier HDAC6 was found to control tumor growth and halt metastasis in triple-negative breast cancer in vivo, according to a new study published in the journal Cancer Research by investigators at the GW Cancer Center.